Alessandra Leone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alessandra Leone has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Giovanni Savini
Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise, 64100 Teramo, Italy
11 shared publications - Alessio Lorusso
Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise “G. Caporale”, 64100 Teramo, Italy
5 shared publications - Liana Teodori
Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise Giuseppe Caporale Teramo Italy
5 shared publications - Cesare Cammà
National Reference Center for Whole Genome Sequencing of Microbial Pathogens, Istituto Zooprofilattico Sperimentale Abruzzo-Molise “G. Caporale”, 64100 Teramo, Italy
4 shared publications - Maurilia Marcacci
Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise “G. Caporale”, 64100 Teramo, Italy
4 shared publications - Annapia Di Gennaro
Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise, 64100 Teramo, Italy
3 shared publications
Latest Publications
- Open Access
- 1 March 2015
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 30, 55-58
A new member of the Pteropine Orthoreovirus species isolated from fruit bats imported to Italy
- 1 March 2015
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 30, 55-58
Open AccessA new member of the Pteropine Orthoreovirus species isolated from fruit bats imported to Italy
- 1 December 2014
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 28, 144-149
Molecular epidemiology of bluetongue virus serotype 1 circulating in Italy and its connection with northern Africa
- 1 December 2014
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 28, 144-149
Molecular epidemiology of bluetongue virus serotype 1 circulating in Italy and its connection with northern Africa
- Open Access
- 27 February 2014
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 2 (1) , e00093-14
Complete Genome Sequence of Bluetongue Virus Serotype 1 Circulating in Italy, Obtained through a Fast Next-Generation Sequencing Protocol
A field strain of the bluetongue virus serotype 1 (BTV-1) was isolated from infected sheep in Sardinia, Italy, in October 2013. The genome was sequenced using Ion Torrent technology. BTV-1 strain SAD2013 belongs to the Western topotype of BTV-1, clustering with BTV-1 strains isolated in Europe and northern Africa since 2006.
- 27 February 2014
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 2 (1) , e00093-14
Open AccessComplete Genome Sequence of Bluetongue Virus Serotype 1 Circulating in Italy, Obtained through a Fast Next-Generation Sequencing Protocol
A field strain of the bluetongue virus serotype 1 (BTV-1) was isolated from infected sheep in Sardinia, Italy, in October 2013. The genome was sequenced using Ion Torrent technology. BTV-1 strain SAD2013 belongs to the Western topotype of BTV-1, clustering with BTV-1 strains isolated in Europe and northern Africa since 2006.
- 1 October 2013
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 19, 81-87
Bluetongue virus serotypes 1 and 4 in Sardinia during autumn 2012: New incursions or re-infection with old strains?
- 1 October 2013
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 19, 81-87
Bluetongue virus serotypes 1 and 4 in Sardinia during autumn 2012: New incursions or re-infection with old strains?
- 1 November 2010
- Published by Elsevier in Veterinary Microbiology
- Vol. 146 (1-2) , 44-50
Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16
- 1 November 2010
- Published by Elsevier in Veterinary Microbiology
- Vol. 146 (1-2) , 44-50
Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16
- 4 December 2009
- Published by Elsevier in Veterinary Microbiology
- Vol. 143 (2-4) , 189-195
Emergence of bluetongue virus serotype 6 in Europe—German field data and experimental infection of cattle
- 4 December 2009
- Published by Elsevier in Veterinary Microbiology
- Vol. 143 (2-4) , 189-195
Emergence of bluetongue virus serotype 6 in Europe—German field data and experimental infection of cattle
- 2 July 2009
- Published by Elsevier in Veterinary Microbiology
- Vol. 138 (1-2) , 92-97
First evidence of bluetongue virus serotype 16 in Croatia
- 2 July 2009
- Published by Elsevier in Veterinary Microbiology
- Vol. 138 (1-2) , 92-97
First evidence of bluetongue virus serotype 16 in Croatia
- 30 July 2008
- Published by Wiley in Zoonoses and Public Health
- Vol. 55 (7) , 361-367
Serological Evidence of USUTU Virus Occurrence in North‐Eastern Italy
Summary: In the recent years, USUTU virus (USUV), a flavivirus of the Japanese encephalitis virus complex, has been reported in Central Europe. As part of a systematic surveillance programme to monitor possible entrance and/or circulation of vector‐borne viruses, since 2001, sentinel‐chicken flocks were placed throughout the Italian territory nearby areas considered at risk of virus introduction. They have been periodically checked for the presence of antibodies against flaviviruses by indirect ELISA, plaque reduction neutralization test for USUTU, West Nile and tick‐borne encephalitis viruses. In July 2007, a sentinel chicken in a flock of 20 animals located within the Ravenna province seroconverted to USUV reaching neutralizing titres up to 1 : 5120. A second chicken seroconverted to the same virus 2 months later. Although no virus was rescued from these animals and from wild or farm birds sampled in the area, these results still provided evidence of the circulation of USUV in north‐eastern Italy.
- 30 July 2008
- Published by Wiley in Zoonoses and Public Health
- Vol. 55 (7) , 361-367
Serological Evidence of USUTU Virus Occurrence in North‐Eastern Italy
Summary: In the recent years, USUTU virus (USUV), a flavivirus of the Japanese encephalitis virus complex, has been reported in Central Europe. As part of a systematic surveillance programme to monitor possible entrance and/or circulation of vector‐borne viruses, since 2001, sentinel‐chicken flocks were placed throughout the Italian territory nearby areas considered at risk of virus introduction. They have been periodically checked for the presence of antibodies against flaviviruses by indirect ELISA, plaque reduction neutralization test for USUTU, West Nile and tick‐borne encephalitis viruses. In July 2007, a sentinel chicken in a flock of 20 animals located within the Ravenna province seroconverted to USUV reaching neutralizing titres up to 1 : 5120. A second chicken seroconverted to the same virus 2 months later. Although no virus was rescued from these animals and from wild or farm birds sampled in the area, these results still provided evidence of the circulation of USUV in north‐eastern Italy.
- 1 October 2007
- Vol. 43 (4) , 807-20
Study of the safety and efficacy of a recombinant vaccine for bluetongue virus serotype 2.
A total of 7 cows, 10 sheep and 10 goats were vaccinated subcutaneously with 5 ml of a recombinant vaccine consisting of synthetic virions containing the four principal proteins (VP2, VP3, VP5 and VP7) of bluetongue virus serotype 2 (BTV-2). The same number of animals and species were vaccinated with 2.5 ml (the normal vaccination dose) and 2 cows, 2 sheep and 2 goats were inoculated with a placebo and the adjuvant added to the vaccine. Animals vaccinated with the normal dose received a booster 14 days after the first injection and 8 sheep a third vaccination 4 months after the second inoculation. One month after the third vaccination, the 8 sheep and another 4 that had never come into contact with the virus were challenged with 1 ml of 10(5.8) TCID(50) of a BTV-2 Italian field isolate. All animals showed competitive enzyme-linked immunosorbent assay (c-ELISA) antibodies starting 14 days following the first vaccination. Conversely, no animal demonstrated neutralising antibodies to BTV-2 after vaccination. Fever (>40 degrees C) was observed in 6 vaccinated animals and 2 controls between 8 and 13 days post challenge. The virus was isolated from all animals from the 7th day post challenge. There was no significant difference in the blood chemical parameters tested and no significant interaction was found in the trial group.
- 1 October 2007
- Vol. 43 (4) , 807-20
Study of the safety and efficacy of a recombinant vaccine for bluetongue virus serotype 2.
A total of 7 cows, 10 sheep and 10 goats were vaccinated subcutaneously with 5 ml of a recombinant vaccine consisting of synthetic virions containing the four principal proteins (VP2, VP3, VP5 and VP7) of bluetongue virus serotype 2 (BTV-2). The same number of animals and species were vaccinated with 2.5 ml (the normal vaccination dose) and 2 cows, 2 sheep and 2 goats were inoculated with a placebo and the adjuvant added to the vaccine. Animals vaccinated with the normal dose received a booster 14 days after the first injection and 8 sheep a third vaccination 4 months after the second inoculation. One month after the third vaccination, the 8 sheep and another 4 that had never come into contact with the virus were challenged with 1 ml of 10(5.8) TCID(50) of a BTV-2 Italian field isolate. All animals showed competitive enzyme-linked immunosorbent assay (c-ELISA) antibodies starting 14 days following the first vaccination. Conversely, no animal demonstrated neutralising antibodies to BTV-2 after vaccination. Fever (>40 degrees C) was observed in 6 vaccinated animals and 2 controls between 8 and 13 days post challenge. The virus was isolated from all animals from the 7th day post challenge. There was no significant difference in the blood chemical parameters tested and no significant interaction was found in the trial group.